Innovation Focus Glympse Bio is dedicated to transforming disease diagnosis and monitoring through innovative protein activity measurement technologies, presenting opportunities to offer advanced diagnostic solutions and related services.
Recent Acquisition Activity Following its acquisition by Sunbird Bio, Glympse is positioned to expand its portfolio into blood-based diagnostics for neurological conditions like Alzheimer's, opening pathways for collaborations in neurodegenerative disease testing.
Strategic Collaborations The company's partnership with Gilead Sciences indicates a strong interest in integrating its diagnostic platform into broader therapeutic and prognostic applications, suggesting potential for joint ventures or licensing deals.
Funding and Growth With over $18 million in funding and a modest revenue base, Glympse is in a growth phase, making it receptive to strategic partnerships that can accelerate product development and market entry within the biotech diagnostic field.
Technology Adaptability Using a tech stack encompassing Docker, SQL, and cloud-based tools, Glympse Bio is primed for scalable, tech-driven diagnostic solutions, which can benefit from software development or integration services tailored for biotech applications.
$100M$250M
$1M$10M
$50M$100M
$1B$10B
$1M$10M
$100M$250M
$500M$1B
$1B$10BGlympse Bio uses 8 technology products and services including Docker, SQL, Twemoji, and more. Explore Glympse Bio's tech stack below.
| Glympse Bio Email Formats | Percentage |
| FLast@glympsebio.com | 76% |
| First@glympsebio.com | 12% |
| Last@glympsebio.com | 8% |
| First.Last@glympsebio.com | 4% |
| FLast@labcentral.org | 99% |
| First.Last@labcentral.org | 1% |
Medical Equipment ManufacturingMassachusetts, United States11-50 Employees
Glympse’s mission is to measure protein activity to transform the way patients are diagnosed, monitored and treated. At Glympse, you’ll find an entrepreneurial team that shares a commitment to excellence, an impatience with the status quo, and a desire to drive innovation for patients in need.
Company Overview
Funding & FinancialsGlympse Bio has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $18M.
Glympse Bio's revenue is estimated to be in the range of $1M
Funding & FinancialsGlympse Bio has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $18M.
Glympse Bio's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com